Germany clears Bharat Biotech’s Covaxin

In a significant development, the German government on Thursday recognised the WHO-listed Bharat Biotech`s Covid-19 vaccine, COVAXIN, for travel to the country starting June 1. The Hyderabad-based vaccine maker confirmed this in a tweet. “Germany has approved Covaxin COVID19 vaccine. The entrants will no longer need proof of vaccination as the Federal Cabinet relaxes restrictions,” Bharat Biotech said on Twitter.

COVAXIN has been approved by Germany. The entrants will no longer need proof of vaccination as the Federal Cabinet relaxes restrictions.#BharatBiotech #COVID19 #COVID19Vaccine #COVAXIN #covaxinapproval #germanytravel #vaccination

0

0